Cargando…
CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes
As the current staging system is imprecise for estimating prognosis of early stage non-small cell lung cancer (NSCLC), it is important to identify other methods for selecting high-risk patients after failed surgical treatment. The aim of the study was to evaluate the expression of 23 genes as putati...
Autores principales: | Kowalczuk, Oksana, Burzykowski, Tomasz, Niklinska, Wieslawa Ewa, Kozlowski, Miroslaw, Chyczewski, Lech, Niklinski, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009141/ https://www.ncbi.nlm.nih.gov/pubmed/24500664 http://dx.doi.org/10.1007/s13277-014-1605-x |
Ejemplares similares
-
Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non–Small Cell Lung Cancer()
por: Kowalczuk, Oksana, et al.
Publicado: (2014) -
Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()
por: Charkiewicz, Radoslaw, et al.
Publicado: (2017) -
Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
por: Niklinski, J., et al.
Publicado: (1996) -
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013) -
K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)